Back to BARCLAYS PLC BARCLAYS PLC

NXTCNXTC
4 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in NEXTCURE INC

Yes. Barclays holds 5,726 shares of NXTC (Nextcure), worth $9,162, as of its Q2 2026 13F filing. It increased the position by 100 shares (+1.8%) from Q1 2026. Barclays has held NXTC since Q3 2025, across 4 quarterly 13F filings.

Current Value

$9,162

Current Shares

5,726

Total Value Change

-$23,806

Total Shares Change

+100

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5,726
+1.8%
$9,1620.0%$1.60
12
2026-Q1
Unchanged
5,626
0.0%
$60,0850.0%$10.68
0
2025-Q4
Unchanged
5,626
0.0%
$79,8330.0%$14.19
0
2025-Q3
New
5,626
-
$32,9680.0%$5.86
30

Other major holders of NXTC: VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used